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ORIGINAL ARTICLE
The effect of video information on anxiety levels in women attending
colposcopy: a randomized controlled trial
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Willem J. G. Melchersd and Ruud L. M. Bekkersa
aDepartment of Obstetrics and Gynaecology, Radboud University Medical Center, Nijmegen, The Netherlands; bDepartment of Obstetrics and
Gynaecology, Amphia Hospital, Breda, The Netherlands; cDepartment of Medical Psychology, Radboud University Medical Center, Nijmegen,
The Netherlands; dDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands
ABSTRACT
Objective: The aim was to investigate whether additional information, in video form, reduces anxiety,
depression and pain levels in women referred for colposcopy.
Material and methods: Between September 2012 and March 2015, 136 patients referred for colpos-
copy were randomized into two study arms. Group A received video information in addition to the
regular information leaflet, and group B (control group) received only the regular information leaflet.
The patients were requested to complete standardized online questionnaires. The first online question-
naire (T1) was pre-randomization, and was completed at home, 5 days prior to the appointment. The
second online questionnaire (T2) was completed directly before the colposcopy appointment, and the
last online questionnaire (T3) was completed directly following colposcopy at the out-patient clinic.
The questionnaires included the Spielberger State-Trait Anxiety Inventory (STAI), the Hospital Anxiety
and Depression Scale (HADS), and the Numeric Rating Scale (NRS) to assess pain.
Results: The STAI state anxiety score was high (44.6), but there was no significant difference in STAI,
HADS and NRS between the two groups at the three measuring points. A post hoc analysis showed
that women with a generally higher baseline anxiety trait had significantly lower HADS anxiety levels
following video information.
Conclusions: Additional information (video) before colposcopy did not significantly reduce anxiety,
depression, and expected or experienced pain, as measured by the STAI, HADS and NRS in patients
attending their first colposcopy appointment. However, most patients positively appreciated the video
information, which may reduce the anxiety of extremely anxious patients.
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Introduction
Every 5 years, women aged 30–60 years in the Netherlands are
invited for a cervical smear taken by their general practitioners
(GPs) or practice assistants (nursing assistants, specifically
trained to take cervical smears). About 77% of the invited
women participate in the national program for cervical screen-
ing every year [1]. At present, 1–2% of the cervical smears
require referral for colposcopy at the gynecologist’s [2].
However, with the introduction of detection of primary high-
risk human papillomavirus (hrHPV) on the cervical smear in
2017, this referral rate is expected to double [3].
Women may experience high levels of anxiety and nega-
tive emotional responses at all stages of screening for cer-
vical cancer [4–7]. Colposcopy has been shown to be
associated with high levels of anxiety, higher than before sur-
gery. These levels are similar to women’s anxiety levels fol-
lowing a screening test that indicates fetal abnormalities [8].
Apart from the fear of having cancer, their concerns consist
of fear of pain, uncertainty about the colposcopic procedure,
disappointment in their own body, sexual anxiety, and wor-
ries about reproduction [6,8].
It has been proven that women who consider the infor-
mation provided by the gynecologist is inadequate have sig-
nificantly higher anxiety levels. Women who have to wait a
long time or who do not have a partner also have signifi-
cantly higher anxiety levels. These high levels of anxiety
before and during colposcopy may have several consequen-
ces including pain, discomfort and failure to return for fol-
low-up [8]. A recent study shows even long-term (12-month)
effects of emotional and physical distress after colposcopy
[9]. Decreasing the levels of fear and anxiety is important to
improve screening efficacy.
Qualitative research indicates that practical and detailed
information provided to women may reduce stress and anx-
iety. Especially preparatory sensory and procedural information
is needed [7,10]. However, some studies show that providing
written information about abnormal cervical smears and col-
poscopy or offering extra information at the individual level by
mail and by phone do not reduce anxiety [4,6].
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It is important to reduce the anxiety of women referred
for colposcopy because of the expected higher referral rates
in the new screening program. Several studies have tried to
reduce anxiety, but most have achieved no positive results
[8]. However, a pilot study has shown that video information
on a videotape reduces anxiety significantly [11]. Since that
study (1999), new, more accessible media have become avail-
able to patients for information gathering. This may lead to a
better understanding of abnormal cervical smears. Therefore,
the primary aim of this study was to evaluate whether digital
video information compared to no additional information is
effective in reducing anxiety, pain and depression in women
who are referred for colposcopy.
Material and methods
Inclusion and randomization
General practitioners refer all women with an abnormal cer-
vical smear for colposcopy. Women who were referred to the
colposcopy clinic of the Radboud University Medical Center
Nijmegen (Radboudumc, The Netherlands) between
September 2012 and March 2015 were invited to participate
in this study. Direct referral indications for colposcopy in the
Netherlands are moderate dyskaryosis or worse (equaling
high-grade squamous intraepithelial lesion). Furthermore,
women with two consecutive smears with [1] abnormal squa-
mous cells of undetermined significance or with low-grade
squamous intraepithelial lesion and [2] a positive hrHPV test
were referred for colposcopy.
All newly referred women older than 18 years who had
adequate knowledge of the Dutch language were eligible for
inclusion. All women referred for colposcopy received the
standard information brochure about the colposcopy proced-
ure with their appointment data by post. A study information
letter and an informed consent form were also sent.
Subsequently, we called all the eligible women by phone
to evaluate their willingness to participate in the study. The
participants received a unique identification number and an
internet link by e-mail, and we asked them to complete an
online questionnaire before their colposcopy appointment.
After the first online questionnaire (T1), the participants were
computer-randomized into one of the two groups; blinding
was not possible in this study. Group A received an internet
link and a password for additional online video information.
They were given access to the video on a secured website
for a maximum of four times from a home computer, tablet
or phone. The control group (group B) received no additional
information. The investigators were notified when the
women started the video information online. Informed con-
sent was obtained from all participants. The local ethics
Committee for Human Research approved the study
(NTR3472).
Questionnaires
The participants were asked to complete three different
online questionnaires at three measuring points: (1) at base-
line before randomization to compare groups, (2) before
colposcopy to measure any effect of the video intervention,
and (3) after colposcopy to measure any long-term effect of
the intervention. The investigators were notified automatic-
ally after completion of every online questionnaire. The first
online questionnaire (T1) was completed at home before col-
poscopy and contained the Hospital Anxiety and Depression
Scale (HADS), the State and Trait Anxiety Inventory (STAI),
the RAND-12 Health Status Inventory (RAND-12 HSI), and the
expected pain with the Numeric Rating Scale (NRS).
All participants were asked to arrive at the clinic at least
15min before the scheduled colposcopy appointment to
complete the second online questionnaire (T2). The second
online questionnaire again contained the HADS, a short ver-
sion of the STAI, the expected pain (NRS) and some add-
itional sociodemographic questions. The third online
questionnaire (T3) contained a short version of the STAI and
the experienced pain (NRS), and it was completed directly
following the colposcopy.
To measure depression before colposcopy, we used the
HADS created by Zigmond and Snaith [12], a 14-item self-
report screening scale. It contains two 7-item scales: one for
anxiety and one for depression. All items are scored on a
4-point scale from 0 to 3.
We used the short version of the STAI to assess the state
and trait anxieties [13]. The state anxiety represents feelings
‘at the present moment’, while the trait anxiety stands for
anxiety ‘in general’. Therefore, differences in state anxiety
may reflect any anxiety differences caused by the video infor-
mation. The state and trait measures each consist of 10 items
measured on a 4-point scale, ranging from ‘not at all’ to ‘very
much’. The total scores range between 20 and 80, with
higher scores indicating a greater anxiety level.
The RAND-12 HSI is a short 12-item version of the RAND-
36 HSI. The purpose of the RAND-12 HSI is to provide
estimated scores for the physical health, mental health and
global health composites of the 36-item instrument [14]. We
used the NRS to measure pain during colposcopy. The scale
ranges from 0 (no pain) to 10 (worst imaginable pain).
Video information
The information video was specifically designed and tested
by women to reduce anxiety before colposcopy. We deter-
mined the content of the video on the basis of an earlier
focus group study [7]. This video included images of the hos-
pital, the outpatient clinic with reception, the waiting and
examination rooms, and the medical staff. A gynecologist
explained abnormal smears, the course of the consultation,
and possible treatment. The aim of this video was to provide
information that might reduce anxiety and stress for women
referred for colposcopy. The duration of the video was
11min.
Sample size and statistical analysis
Sixty-four participants were needed for each group in order
to find a decrease of 6 points on the STAI scores with 80%
power, a 5% difference between both groups, and a standard
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deviation of 12, based on the previous research [4].
Therefore, we needed a total of 128 participants. Analyses
were done by intention to treat. We used Student’s t-test for
scale variables with a normal distribution and the
Mann–Whitney U-test for ordinal or continuous variables
without normal distribution. We used SPSS version 20 (IBM,
Armonk, New York) for all statistical analyses. Additional
information on videotape might give more benefit to women
who are more anxious. Therefore, we analyzed the data for
women with high trait anxiety at the measurement moment
T1 separately in a post-hoc analysis. We also did a per-proto-
col analysis.
Results
A total of 151 women were included in the study between
September 2012 and March 2015. Fifteen (9.9%) women
were excluded because they did not complete the first ques-
tionnaire before their appointments (n¼ 5) or for logistic rea-
sons (n¼ 10: illness, holiday and computer/internet
connection failure). We randomly assigned 136 women to
group A (n¼ 66) and group B (n¼ 70). Three women in
group A and five in group B were not included in the ana-
lysis because they did not complete the second question-
naire. There were then 63 women in group A and 65 women
in group B for analysis (Figure 1). Nine (14.3%) women in
group A did not watch the information video prior to
colposcopy.
Baseline and clinical characteristics
The first questionnaire was completed within 5 days (range
1–48) before the colposcopy appointment. No statistical dif-
ferences in baseline characteristics were found between
group A and group B (Table 1). The anxiety and depression
levels, as well as physical, mental and overall health were
comparable for the two groups. The mean STAI state anxiety
levels were 39.3 in group A and 39.2 in group B (p¼ .938).
The mean STAI trait anxiety levels were 37.4 in group A and
35.0 in group B (p¼ .168). The expected pain measured with
the NRS was 4.5 in both groups (p¼ .936).
Outcome measures
Table 2 presents the outcome measures according to inten-
tion to treat. Neither the state anxiety levels measured by
the STAI nor the anxiety or depression levels measured by
the HADS were significantly different between the two
groups after the video information. The mean STAI state anx-
iety levels were 44.3 in group A and 44.9 in group B
(p¼ .752). The mean HADS anxiety levels were 6.2 for group
A and 6.7 for group B (p¼ .491). The mean HADS depression
levels were 2.8 in group A and 3.4 in group B (p¼ .406).
Expected pain measured with the NRS showed no significant
difference between the groups (p¼ .342).
The NRS was measured after colposcopic examination in
the last questionnaire. Group A had a mean NRS score of 3.9
and group B, 4.1 (p¼ .602). Several participants remarked in
the last questionnaire that they really appreciated the video
information. Some quotes from the last questionnaire: ‘It was
very pleasant to see the video in advance. It really gave me
an impression what to expect’. ‘The information video was
very clear and, as a result, I was well prepared’. ‘After reading
the information leaflet I became more anxious. After watch-
ing the video I was less anxious’. (The quotes have been
translated from Dutch to English.) Only one participant said
that neither the information leaflet nor the information video
reassured her.
Eligible for
randomisation
(n = 151)
Randomised
1:1
(n = 136)
Excluded (n = 15):
• First questionnaire (T1) was not
completed (n = 5)
• Not randomised for logistic
reasons (n = 10)
Group A (additional video
information)
(n = 66)
Group B (control group)
(n = 70)
Group A (additional video
information)
(n = 63)
Group B (control group)
(n = 65)
Second
questionnaire (T2)
was not completed
( n = 5)
Second
questionnaire (T2)
was not completed
(n = 3)
Figure 1. Flowchart.
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Post-hoc analysis
In the post-hoc analysis, we explored whether women with a
generally higher anxiety level benefit more from video infor-
mation. Twenty-four women in group A and 16 women in
group B with a trait anxiety level higher than 38 at T1 were
identified. The HADS anxiety level of the 24 women in group
A was significantly lower after watching the video at meas-
urement moment T2: 7.2 in group A and 9.0 in group B
(p¼ .018). However, the STAI showed no significant differ-
ence (49.8 in group A versus 53.7 in group B; p¼ .132).
Furthermore, in the per-protocol analyses, there were 54
women in group A and 74 women in group B. There were
no significant differences between the two groups in STAI or
HADS.
Discussion
In this randomized-controlled study, we studied anxiety,
depression, and expected pain between two groups of
women referred for colposcopy. One group did receive add-
itional information (video) before colposcopy and the other
did not. This additional information before colposcopy did
not significantly reduce anxiety, depression or expected pain,
Table 1. Baseline and clinical characteristics.
Group A (additional
video information) n = 63
Group B
(control) n = 65 p Value
Age
Mean (range in years) 35 (22–60) 37 (21–61) .359*
Highest level of education
Primary education 0 (0.0%) 0 (0.0%) .279**
Preparatory secondary vocational education 12 (19.0%) 6 (9.2%)
Senior general, secondary vocational or pre-university education 17 (27.0%) 21 (32.3%)
Higher professional education or university 34 (54.0%) 38 (58.5%)
Marital state
Single, divorced, or widowed 21 (33.3%) 26 (40.0%) .467**
Steady relationship, married, and/or cohabiting 42 (66.7%) 39 (60.0%)
Parity
No 28 (44.4%) 33 (50.8%) .485**
Yes 35 (55.6%) 32 (49.2%)
Reason for referral
National screening 21 (33.3%) 19 (29.2%) .291**
Repeated national screening 15 (23.8%) 27 (41.5%)
Complaints 20 (31.7%) 14 (21.5%)
Fertility treatment pathway 4 (6.3%) 4 (6.2%)
Control 2 (3.2%) 1 (1.5%)
Social support to clinic
No 23 (36.5%) 17 (26.2%) .254**
Yes 40 (63.5%) 48 (73.8%)
Had read leaflet at T1
No 3 (4.8%) 8 (12.3%) .206**
Yes 60 (95.2%) 57 (87.7%)
Had read leaflet at T2
No 0 (0.0%) 1 (1.5%) 1.000**
Yes 63 (100.0%) 64 (98.5%)
Treatment during colposcopy
No 25 (39.7%) 23 (35.4%) .581**
Yes 35 (55.6%) 41 (63.0%)
Missing data 3 (4.6%) 1 (1.5%)
Completed the first questionnaire before colposcopy
Mean (range in days) 5 (1–48) 5 (1–29) .776*
HADS anxiety before intervention
Mean (SD) 6.1 (3.6) 6.6 (4.3) .503*
HADS depression before intervention
Mean (SD) 3.0 (3.5) 3.1 (3.6) .882*
STAI state anxiety before intervention
Mean (SD) 39.3 (11.9) 39.2 (12.1) .938*
Median 36.5 38.5
STAI trait anxiety
Mean (SD) 37.4 (10.9) 35.0 (8.5) .168*
Median 35.0 34.0
NRS expected pain before intervention
Mean (SD) 4.5 (2.4) 4.5 (2.2) .936*
RAND-12 physical health
Mean (SD) 47.7 (10.7) 50.6 (7.7) .080*
RAND-12 mental health
Mean (SD) 47.2 (10.0) 48.9 (8.6) .303*
RAND-12 global health
Mean (SD) 46.8 (10.7) 49.4 (8.1) .121*
*Student’s t-test.
**Mann–Whitney U-test.
HADS, Hospital and Anxiety Depression Scale; NRS, Numeric Rating Scale; RAND-12, RAND-12 Health Status Inventory; STAI, State-Trait Anxiety Inventory.
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as measured by the STAI, HADS and NRS for women attend-
ing their first colposcopy appointment.
This result contrasts with the result of Freeman–Wang and
colleagues’ pilot study [11]. Their study reports a statistical
difference on the STAI state anxiety scale between the inter-
vention group and the control group. The video that
Freeman–Wang used was comparable to the video informa-
tion used in this study in that it contains images of the clinic
as well as the nursing and medical staff, outlines the nature
of abnormal smears, and explains the consultation and/or
treatment that may follow [11]. A possible explanation for
the lack of effect of video information in our study may be
the easy access to a variety of information sources via inter-
net nowadays, which was lacking at the time of the
Freeman–Wang study in the late 1990s. An indication sup-
porting this theory is the difference in mean state anxiety
levels between the studies. The mean state anxiety score of
the 128 women visiting our clinic was 44.6 (SD 10.8), which
is lower than the average of 51.1 (SD 13.3) found in the
Freeman–Wang study. The anxiety scores in the English study
may have been higher because the participants had fewer
opportunities to get information themselves. Additionally,
our post-hoc analysis shows that women with higher anxiety
levels do benefit from video information, and this may
explain the discrepancy between our study and
Freeman–Wang’s study.
In the Dutch population, the mean state anxiety score of
adult women is 38.8, with an SD of 13.2 [13]. Before colpos-
copy, women experience high levels of distress and an ele-
vated state anxiety level [6,15]. The mean observed state
anxiety score in our study was 44.6, which is concordant with
other studies [4,6,16,17]. Interventions consisting of individu-
ally targeted information did not reduce anxiety. However,
high levels of stress and anxiety may also be associated with
better adherence to treatment and follow-up after colposcopy,
as fear of cancer may be motivating [4]. Nevertheless, evidence
regarding this potential correlation remains inconclusive [18].
Pain expectations are also associated with pre-colposcopy
distress [16]. Kola et al.’s [16] earlier study shows that
expected pain evokes a natural, negative response. Our study
shows a slightly lower expected pain score in the video
information group, but this was not significant when com-
pared to the control group score.
In Bosgraaf and colleagues’ [7] focus group study, psycho-
logical stress before colposcopy was caused by unsatisfactory
explanations of abnormal smears and the colposcopy proced-
ure itself. We note that GPs often do not inform patients
beforehand about the possible abnormal results of cervical
smear tests and how such results should be interpreted [19].
It is difficult for GPs to reassure women that most of the
positive smear results do not necessarily mean cancer [19].
To improve the cervical screening program, it is important
that women receive standardized information. Video informa-
tion is a simple intervention, and it could reduce consultation
time. It has the additional advantage that every woman
receives the same information.
One of the limitations of this study is the lack of any pre-
defined clinically important differences in STAI score in the
literature. We have used a 6-point decrease as a clinically
relevant difference because this has been used in other stud-
ies. However, it remains uncertain whether a 6-point
decrease in anxiety is clinically relevant.
In conclusion, video information did not significantly
reduce the anxiety levels of women referred for their first col-
poscopy. Nevertheless, there was a high patient satisfaction
rate, and a small trend in anxiety reduction in the video infor-
mation group, especially among the more anxious women.
Because video information provides all the women with the
same type of correct information and because women
responded positively to the video, clinics should consider
offering video information to women referred for colposcopy.
Disclosure statement
The authors declare that they have no conflict of interest with regard to
any of the material presented in this paper.
Contribution to authorship
We confirm that each author has contributed materially to the paper
and that no individuals qualified for authorship have been omitted. The
order of authorship is related to the relative individual contributions.
Table 2. Outcome measures.
Group A (additional
video information)
n = 63
Group B (control)
n = 65 Total n = 128 p Value
HADS anxiety after intervention
Mean (SD) 6.2 (4.4) 6.7 (4.6) 6.4 (4.5) .491*
HADS depression after intervention
Mean (SD) 2.8 (3.6) 3.4 (3.9) 3.1 (3.8) .406*
STAI state anxiety after intervention
Mean (SD) 44.3 (10.7) 44.9 (11.0) 44.6 (10.8) .752*
Median 44.0 44.0 44.0 .706**
NRS expected pain after intervention
Mean (SD) 4.2 (2.5) 4.6 (2.2) 4.4 (2.3) .342*
STAI state anxiety after colposcopy
Mean (SD) 37.5 (10.5) 40.4 (11.7) 39.0 (11.2) .144*
Median 35.5 39.0 37.0 .185**
NRS experienced pain during colposcopy
Mean (SD) 3.9 (2.6) 4.1 (2.8) 4.0 (2.7) .602*
*Student’s t-test.
**Mann–Whitney U-test.
HADS, Hospital and Anxiety Depression Scale; NRS, Numeric Rating Scale; STAI, State-Trait Anxiety Inventory.
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